Literature DB >> 21454350

Variability in urinary oxalate measurements between six international laboratories.

Naim M Maalouf1, Beverley Adams Huet, Andreas Pasch, John C Lieske, John R Asplin, Roswitha Siener, Albrecht Hesse, Jean-Marc Nuoffer, Felix J Frey, John Knight, Ross P Holmes, Joseph E Zerwekh, Olivier Bonny.   

Abstract

BACKGROUND: Hyperoxaluria is a major risk factor for kidney stone formation. Although urinary oxalate measurement is part of all basic stone risk assessment, there is no standardized method for this measurement.
METHODS: Urine samples from 24-h urine collection covering a broad range of oxalate concentrations were aliquoted and sent, in duplicates, to six blinded international laboratories for oxalate, sodium and creatinine measurement. In a second set of experiments, ten pairs of native urine and urine spiked with 10 mg/L of oxalate were sent for oxalate measurement. Three laboratories used a commercially available oxalate oxidase kit, two laboratories used a high-performance liquid chromatography (HPLC)-based method and one laboratory used both methods.
RESULTS: Intra-laboratory reliability for oxalate measurement expressed as intraclass correlation coefficient (ICC) varied between 0.808 [95% confidence interval (CI): 0.427-0.948] and 0.998 (95% CI: 0.994-1.000), with lower values for HPLC-based methods. Acidification of urine samples prior to analysis led to significantly higher oxalate concentrations. ICC for inter-laboratory reliability varied between 0.745 (95% CI: 0.468-0.890) and 0.986 (95% CI: 0.967-0.995). Recovery of the 10 mg/L oxalate-spiked samples varied between 8.7 ± 2.3 and 10.7 ± 0.5 mg/L. Overall, HPLC-based methods showed more variability compared to the oxalate oxidase kit-based methods.
CONCLUSIONS: Significant variability was noted in the quantification of urinary oxalate concentration by different laboratories, which may partially explain the differences of hyperoxaluria prevalence reported in the literature. Our data stress the need for a standardization of the method of oxalate measurement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454350      PMCID: PMC3254161          DOI: 10.1093/ndt/gfr147

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  16 in total

1.  Rapid Communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate.

Authors:  Charles Y C Pak; Beverley Adams-Huet; John R Poindexter; Margaret S Pearle; Roy D Peterson; Orson W Moe
Journal:  Kidney Int       Date:  2004-11       Impact factor: 10.612

2.  Determination of oxalate in urine using oxalate oxidase: comparison with oxalate decarboxylase.

Authors:  G Kohlbecker; L Richter; M Butz
Journal:  J Clin Chem Clin Biochem       Date:  1979-05

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Assay of urinary oxalate: six methodologies compared.

Authors:  J E Zerwekh; E Drake; J Gregory; D Griffith; A F Hofmann; M Menon; C Y Pak
Journal:  Clin Chem       Date:  1983-11       Impact factor: 8.327

5.  Determination of urinary oxalate by high-performance liquid chromatography.

Authors:  H Hughes; L Hagen; R A Sutton
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

6.  Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.

Authors:  G C Curhan; W C Willett; F E Speizer; M J Stampfer
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

7.  Factors affecting measurement of urinary oxalate.

Authors:  B C Mazzachi; J K Teubner; R L Ryall
Journal:  Clin Chem       Date:  1984-08       Impact factor: 8.327

8.  Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach.

Authors:  Michel Daudon; Jean-Christophe Doré; Paul Jungers; Bernard Lacour
Journal:  Urol Res       Date:  2004-05-04

9.  Determinants of 24-hour urinary oxalate excretion.

Authors:  Eric N Taylor; Gary C Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 8.237

10.  The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?

Authors:  W G Robertson; M Peacock
Journal:  Nephron       Date:  1980       Impact factor: 2.847

View more
  5 in total

1.  Update on the evaluation of repeated stone formers.

Authors:  Adam O Kadlec; Thomas M Turk
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

2.  Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.

Authors:  Sushrut S Waikar; Anand Srivastava; Ragnar Palsson; Tariq Shafi; Chi-Yuan Hsu; Kumar Sharma; James P Lash; Jing Chen; Jiang He; John Lieske; Dawei Xie; Xiaoming Zhang; Harold I Feldman; Gary C Curhan
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

3.  SLIPS-LAB-A bioinspired bioanalysis system for metabolic evaluation of urinary stone disease.

Authors:  Hui Li; Eugene Shkolyar; Jing Wang; Simon Conti; Alan C Pao; Joseph C Liao; Tak-Sing Wong; Pak Kin Wong
Journal:  Sci Adv       Date:  2020-05-22       Impact factor: 14.136

4.  Practice patterns of kidney stone management across European and non-European centers: an in-depth investigation from the European Renal Stone Network (ERSN).

Authors:  Pietro Manuel Ferraro; Robert Unwin; Olivier Bonny; Giovanni Gambaro
Journal:  J Nephrol       Date:  2020-09-12       Impact factor: 3.902

5.  Urine and stone analysis for the investigation of the renal stone former: a consensus conference.

Authors:  James C Williams; Giovanni Gambaro; Allen Rodgers; John Asplin; Olivier Bonny; Antonia Costa-Bauzá; Pietro Manuel Ferraro; Giovanni Fogazzi; Daniel G Fuster; David S Goldfarb; Félix Grases; Ita P Heilberg; Dik Kok; Emmanuel Letavernier; Giuseppe Lippi; Martino Marangella; Antonio Nouvenne; Michele Petrarulo; Roswitha Siener; Hans-Göran Tiselius; Olivier Traxer; Alberto Trinchieri; Emanuele Croppi; William G Robertson
Journal:  Urolithiasis       Date:  2020-10-13       Impact factor: 3.436

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.